Pediatric IBD: Lymphoma Risk Very Low With Anti-TNF Agents

<![CDATA[]]>(MedPage Today) — AUSTIN — Exposure to tumor necrosis factor (TNF) inhibitors was not linked to lymphoma malignancy among children and adolescents with inflammatory bowel disease (IBD), a researcher said here.
Among 9,281 patients with pediatric…

Source link

Related posts

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk


FDA: Illnesses Tied to Fresh Crab Meat Imported From Venezuela


HNF4 Regulates Fatty Acid Oxidation and is Required for Renewal of Intestinal Stem Cells in Mice


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy